Zhao Dong, Grundy Scott M, Wang Wei, Liu Jing, Zeng Zhechun, Wang Wenhua, Wu Zhaosu
Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Am J Cardiol. 2007 Sep 1;100(5):835-9. doi: 10.1016/j.amjcard.2007.03.103. Epub 2007 Jun 14.
This study aimed to examine the relation between central obesity and other metabolic disorders of metabolic syndrome (MS) and compare the long-term risks of cardiovascular disease (CVD) between patients with MS with or without central obesity in middle-aged Chinese. The study included 30,378 Chinese aged 35 to 64 years at baseline with complete measurements for MS components and follow-up data for new acute CVD events from 1992 to 2003. The 10-year relative and absolute CVD risks in the MS groups with or without central obesity were compared. Results showed that 78% of patients with MS had central obesity and 22% with MS had no central obesity, diagnosed using updated Adult Treatment Panel III criteria with cut-off values appropriate for Asian populations. Central obesity, as well as other metabolic disorders in patients with MS, except for increased triglycerides, increased CVD risk significantly. There were no significant differences in 10-year absolute and relative risks of coronary heart disease events and ischemic CVD events between the 2 MS groups. In conclusion, MS with or without central obesity has a significantly increased 10-year risk of CVD in middle-aged Chinese.
本研究旨在探讨中心性肥胖与代谢综合征(MS)的其他代谢紊乱之间的关系,并比较中国中年人群中伴有或不伴有中心性肥胖的MS患者发生心血管疾病(CVD)的长期风险。该研究纳入了30378名年龄在35至64岁之间的中国人群,他们在基线时对MS各组分进行了完整测量,并提供了1992年至2003年期间新发急性CVD事件的随访数据。比较了伴有或不伴有中心性肥胖的MS组的10年CVD相对风险和绝对风险。结果显示,采用适合亚洲人群的更新版成人治疗小组III标准进行诊断,78%的MS患者存在中心性肥胖,22%的MS患者无中心性肥胖。除甘油三酯升高外,MS患者的中心性肥胖以及其他代谢紊乱均显著增加CVD风险。两组MS患者在冠心病事件和缺血性CVD事件的10年绝对风险和相对风险方面无显著差异。总之,在中国中年人群中,伴有或不伴有中心性肥胖的MS患者发生CVD的10年风险均显著增加。